Posted November 03, 2008 in Blog, Botox and Facial Fillers, Plastic Surgery in the News, Uncategorized
Plastic Surgery Practice (PSP) reports in their current e-report that “Lipotec has introduced a nonsurgical way to give patients full lips, a new method of vehiculizing hyaluronic acid called Hilurlip. The name doesn’t exactly roll off the tongue, but the manufacturer is making big claims for its product. Hilurlip is an oil suspension containing particles of sodium hyaluronate, which is processed to the point at which the particle size is reduced and homogenized up to 1µm—the company claims that this enhances the product’s penetration and efficacy, and can provide up to an 18% increase in lip volume. These particles expand when they come in contact with skin water, and reportedly provide long-term plumping of the lips. Hilurlip also contains the tripeptide GHK, a well-known RCS scavenger that protects the lips against photodamage and loss of collagen elasticity. The product can be incorporated into water-free lip care formulations, such as glosses and lip balms. The company advises against using the product in lipsticks. Source: Lipotec” I for one will believe it when I see it. I remain skeptical at this time about product claims of penetrating topically through the skin barrier to impose their effect. How many millions of dollars have been wasted on Strivectin anti-wrinkle cream, and its claims that it is “better than Botox”? Please comment if you have had any experience with these products.
